Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Migraine - a borderland disease to epilepsy: near it but not of it

J. Paungarttner, M. Quartana, L. Patti, B. Sklenárová, F. Farham, IH. Jiménez, MG. Soylu, IM. Vlad, S. Tasdelen, T. Mateu, O. Marsico, F. Reina, V. Tischler, C. Lampl, European Headache Federation School of Advanced Studies (EHF – SAS)

. 2024 ; 25 (1) : 11. [pub] 20240126

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc24007501

BACKGROUND: Migraine and epilepsy are two paroxysmal chronic neurological disorders affecting a high number of individuals and being responsible for a high individual and socioeconomic burden. The link between these disorders has been of interest for decades and innovations concerning diagnosing and treatment enable new insights into their relationship. FINDINGS: Although appearing to be distinct at first glance, both diseases exhibit a noteworthy comorbidity, shared pathophysiological pathways, and significant overlaps in characteristics like clinical manifestation or prophylactic treatment. This review aims to explore the intricate relationship between these two conditions, shedding light on shared pathophysiological foundations, genetic interdependencies, common and distinct clinical features, clinically overlapping syndromes, and therapeutic similarities. There are several shared pathophysiological mechanisms, like CSD, the likely underlying cause of migraine aura, or neurotransmitters, mainly Glutamate and GABA, which represent important roles in triggering migraine attacks and seizures. The genetic interrelations between the two disorders can be observed by taking a closer look at the group of familial hemiplegic migraines, which are caused by mutations in genes like CACNA1A, ATP1A2, or SCN1A. The intricate relationship is further underlined by the high number of shared clinical features, which can be observed over the entire course of migraine attacks and epileptic seizures. While the variety of the clinical manifestation of an epileptic seizure is naturally higher than that of a migraine attack, a distinction can indeed be difficult in some cases, e.g. in occipital lobe epilepsy. Moreover, triggering factors like sleep deprivation or alcohol consumption play an important role in both diseases. In the period after the seizure or migraine attack, symptoms like speech difficulties, tiredness, and yawning occur. While the actual attack of the disease usually lasts for a limited time, research indicates that individuals suffering from migraine and/or epilepsy are highly affected in their daily life, especially regarding cognitive and social aspects, a burden that is even worsened using antiseizure medication. This medication allows us to reveal further connections, as certain antiepileptics are proven to have beneficial effects on the frequency and severity of migraine and have been used as a preventive drug for both diseases over many years. CONCLUSION: Migraine and epilepsy show a high number of similarities in their mechanisms and clinical presentation. A deeper understanding of the intricate relationship will positively advance patient-oriented research and clinical work.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24007501
003      
CZ-PrNML
005      
20240423160020.0
007      
ta
008      
240412s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s10194-024-01719-0 $2 doi
035    __
$a (PubMed)38273253
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Paungarttner, Jakob $u Headache Medical Center Linz, Linz, Austria
245    10
$a Migraine - a borderland disease to epilepsy: near it but not of it / $c J. Paungarttner, M. Quartana, L. Patti, B. Sklenárová, F. Farham, IH. Jiménez, MG. Soylu, IM. Vlad, S. Tasdelen, T. Mateu, O. Marsico, F. Reina, V. Tischler, C. Lampl, European Headache Federation School of Advanced Studies (EHF – SAS)
520    9_
$a BACKGROUND: Migraine and epilepsy are two paroxysmal chronic neurological disorders affecting a high number of individuals and being responsible for a high individual and socioeconomic burden. The link between these disorders has been of interest for decades and innovations concerning diagnosing and treatment enable new insights into their relationship. FINDINGS: Although appearing to be distinct at first glance, both diseases exhibit a noteworthy comorbidity, shared pathophysiological pathways, and significant overlaps in characteristics like clinical manifestation or prophylactic treatment. This review aims to explore the intricate relationship between these two conditions, shedding light on shared pathophysiological foundations, genetic interdependencies, common and distinct clinical features, clinically overlapping syndromes, and therapeutic similarities. There are several shared pathophysiological mechanisms, like CSD, the likely underlying cause of migraine aura, or neurotransmitters, mainly Glutamate and GABA, which represent important roles in triggering migraine attacks and seizures. The genetic interrelations between the two disorders can be observed by taking a closer look at the group of familial hemiplegic migraines, which are caused by mutations in genes like CACNA1A, ATP1A2, or SCN1A. The intricate relationship is further underlined by the high number of shared clinical features, which can be observed over the entire course of migraine attacks and epileptic seizures. While the variety of the clinical manifestation of an epileptic seizure is naturally higher than that of a migraine attack, a distinction can indeed be difficult in some cases, e.g. in occipital lobe epilepsy. Moreover, triggering factors like sleep deprivation or alcohol consumption play an important role in both diseases. In the period after the seizure or migraine attack, symptoms like speech difficulties, tiredness, and yawning occur. While the actual attack of the disease usually lasts for a limited time, research indicates that individuals suffering from migraine and/or epilepsy are highly affected in their daily life, especially regarding cognitive and social aspects, a burden that is even worsened using antiseizure medication. This medication allows us to reveal further connections, as certain antiepileptics are proven to have beneficial effects on the frequency and severity of migraine and have been used as a preventive drug for both diseases over many years. CONCLUSION: Migraine and epilepsy show a high number of similarities in their mechanisms and clinical presentation. A deeper understanding of the intricate relationship will positively advance patient-oriented research and clinical work.
650    _2
$a lidé $7 D006801
650    12
$a migréna $x diagnóza $x genetika $x epidemiologie $7 D008881
650    12
$a epilepsie $x etiologie $x genetika $7 D004827
650    12
$a migréna s aurou $x genetika $7 D020325
650    _2
$a antikonvulziva $x terapeutické užití $7 D000927
650    _2
$a komorbidita $7 D015897
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Quartana, Martina $u Department of Sciences for Health Promotion and Mother-and Childcare "G. D'Alessandro", University of Palermo, Palermo, Italy
700    1_
$a Patti, Lucrezia $u Department of Sciences for Health Promotion and Mother-and Childcare "G. D'Alessandro", University of Palermo, Palermo, Italy
700    1_
$a Sklenárová, Barbora $u St. Anne's University Hospital and Masaryk University, Brno, Czech Republic
700    1_
$a Farham, Fatemeh $u Headache Department, Iranian Center of Neurological Researchers, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
700    1_
$a Jiménez, Inés Hernando $u Department of Neurology, Severo Ochoa University Hospital, Madrid, Spain
700    1_
$a Soylu, M Gokcen $u Department of Neurology, Bakırköy Prof. Dr. Mazhar Osman Mental Health and Neurological Diseases Education and Research Hospital, Istanbul, Turkey
700    1_
$a Vlad, Irina Maria $u Department of Neurosciences, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania $u RoNeuro Institute for Neurological Research and Diagnostic, Cluj-Napoca, Romania
700    1_
$a Tasdelen, Semih $u Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
700    1_
$a Mateu, Teresa $u Department of Neurology, Vall d'Hebron University Hospital, Barcelona, Spain $u Department of Neurology, Fundació Sanitària Mollet, Mollet del Vallès, Barcelona, Spain
700    1_
$a Marsico, Oreste $u Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy $u Regional Epilepsy Centre, Great Metropolitan "Bianchi-Melacrino-Morelli Hospitall", Reggio Calabria, Italy
700    1_
$a Reina, Federica $u NeuroTeam Life&Science, Spin-off University of Palermo, Palermo, Italy
700    1_
$a Tischler, Viktoria $u Headache Medical Center Linz, Linz, Austria $u Department of Neurology and Stroke Unit, Konventhospital Barmherzige Brüder Linz, Linz, Austria
700    1_
$a Lampl, Christian $u Headache Medical Center Linz, Linz, Austria. christian.lampl@bblinz.at $u Department of Neurology and Stroke Unit, Konventhospital Barmherzige Brüder Linz, Linz, Austria. christian.lampl@bblinz.at
710    2_
$a European Headache Federation School of Advanced Studies (EHF – SAS)
773    0_
$w MED00005758 $t The Journal of headaches and pain $x 1129-2377 $g Roč. 25, č. 1 (2024), s. 11
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38273253 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423160016 $b ABA008
999    __
$a ok $b bmc $g 2081478 $s 1217268
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 25 $c 1 $d 11 $e 20240126 $i 1129-2377 $m The Journal of headaches and pain $n J Headache Pain $x MED00005758
LZP    __
$a Pubmed-20240412
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace